WuXi PharmaTech Launches Talent Flow with Acquired U.S. Firm AppTec
This article was originally published in PharmAsia News
Executive Summary
BEIJING - WuXi PharmaTech, one of China's leading contract research organizations, is moving rapidly to integrate operations and foster a talent flow with its recently acquired American biologics outfit AppTec Laboratory Services
You may also be interested in...
WuXi Forms JV With PRA To Expand Clinical Services In China
WuXi PharmaTech forms a joint venture with U.S. contract research organization PRA to grow its clinical capabilities in China; the move expands PRA’s reach to 16 Chinese cities.
WuXi PharmaTech Lays Off One-fifth Of U.S. Workforce Months After Acquiring American Biologics Firm AppTec
BEIJING - Less than one year after acquiring the U.S.-based biologics outfit AppTec Laboratory Services in a $160-million deal, WuXi PharmaTech's senior management is preparing to lay off one-fifth of AppTec's 500 employees
WuXi PharmaTech Lays Off One-fifth Of U.S. Workforce Months After Acquiring American Biologics Firm AppTec
BEIJING - Less than one year after acquiring the U.S.-based biologics outfit AppTec Laboratory Services in a $160-million deal, WuXi PharmaTech's senior management is preparing to lay off one-fifth of AppTec's 500 employees